Uxin (UXIN) Cash & Equivalents (2016 - 2025)

Uxin has reported Cash & Equivalents for 10 years, with the latest figure at $11.7 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents rose 234.76% year-over-year to $11.7 million; the trailing twelve-month figure through Dec 2025 stood at $11.7 million (up 234.76% YoY), and the FY2025 full-year result was $11.9 million, up 245.06% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $11.7 million, up from $10641.5 in the prior quarter.
• The five-year high for Cash & Equivalents was $2.4 billion in Q3 2023, with the low at $3424.0 in Q3 2022.
• Historically, Cash & Equivalents has averaged $132.2 million across 5 years, with a median of $10.6 million in 2025.
• Annual changes were most pronounced in 2022 — Cash & Equivalents slumped 99.99% — and 2023, when it jumped 71183495.21%.
• Uxin's Cash & Equivalents stood at $23.4 million in 2021, then slumped by 99.94% to $15088.0 in 2022, then surged by 17711.98% to $2.7 million in 2023, then soared by 30.08% to $3.5 million in 2024, then jumped by 234.76% to $11.7 million in 2025.
• The last three Cash & Equivalents figures came in at $11.7 million (Q4 2025), $10641.5 (Q3 2025), and $9.5 million (Q2 2025), per Business Quant data.